about
Role of CX3CR1 receptor in monocyte/macrophage driven neovascularizationSystemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial InfarctionLipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosisPregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the platelet-fibrinogen interactionLentiviral tracking of vascular differentiation in bone marrow progenitor cells.Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the ratSmooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation.Role of the gut in modulating lipoprotein metabolism.Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1.Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice.Nitric oxide synthase gene transfer as a tool to study biology of endothelial cells.Acute STEMI in the setting of a single coronary artery anomalyFunctional food addressing heart health: do we have to target the gut microbiota?Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells.Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis.A new source of endothelial progenitor cells--vascular biology redefined?Myocardial-cell replacement: the science, the clinic and the future.Cell therapy for cardiovascular disease: what cells, what diseases and for whom?Targeting angiogenesis versus myogenesis with cardiac cell therapy.Plaque neovascularization and antiangiogenic therapy for atherosclerosis.Fractalkine in rheumatoid arthritis: a review to date.Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.Clinical potential of adult vascular progenitor cells.Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam".New therapeutic potential of microRNA treatment to target vulnerable atherosclerotic lesions and plaque rupture.Regenerative approaches to post-myocardial infarction heart failure.Fibrin as a delivery system in wound healing tissue engineering applications.Identification of a Klf4-dependent upstream repressor region mediating transcriptional regulation of the myocardin gene in human smooth muscle cells.Sugar-coated: exopolysaccharide producing lactic acid bacteria for food and human health applications.A Novel Selectable Islet 1 Positive Progenitor Cell Reprogrammed to Expandable and Functional Smooth Muscle Cells.Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction.Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.Molecular biology and gene transfer in atherosclerosis in the stenting era.Genome Sequence of the Heteropolysaccharide-Producing Strain Lactobacillus mucosae DPC 6426Myeloid lineage of human endothelial outgrowth cells circulating in blood and vasculogenic endothelial-like cells in the diseased vessel wall.Smooth muscle progenitor cells in human blood.Differential endothelial coverage, response to injury and neointimal integration of CX3CR1/smooth muscle-like cells after carotid or femoral arterial injury.Fatal coronary artery disease after unrelated donor bone marrow transplantation.Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia.
P50
Q27313463-272949BE-EF4D-4600-A05D-C64A67B0D28CQ27318728-03C8342B-8FAD-42C1-849F-8889E56F3DBDQ28204187-D3900AC2-AA8A-43DA-936A-E0BA6AF86C61Q28595015-E58EB93C-565A-42B5-91FF-D8CAEDF81CD5Q33498178-B3188998-25C3-43BD-A45F-0C5847350A6AQ34052346-20A4BC10-1C51-4D53-8EDB-C04F4D12A9FDQ34960327-FDEFF39B-FD40-45B4-8CA6-7926D4D6547FQ35192357-415BA452-3C7D-475B-BC29-DFCDFE18680AQ35296718-67C420F6-290D-45B7-A528-7139359C9308Q35336070-C7475BD4-A93E-42EF-9CCF-1B11CADDE4EDQ35538608-0B441584-C0F4-4CFC-BE31-4AEAAAB2108CQ35614561-C7A10FF6-A676-42FA-B671-667AB4C6AF86Q35787905-53A33F97-F13F-4571-91AF-BF89D5EB592CQ35799761-90E9A8C4-6DBC-4827-A2C1-0EB3D7CE4C90Q36132926-D13F06FE-BBD4-4AAC-83FB-CC135101AA20Q36135332-F02D19A6-9AC9-4492-866D-5173B00002ADQ36160391-E95BDCE2-073A-4641-8765-EFB2333DB27DQ36304191-0B487B44-3F39-4427-9A6E-8E8455D06EDEQ36304220-F616F8FB-5485-4C4E-B3CC-2DB9B586B459Q36642702-F403853E-4BBC-41EF-81E3-917C1A9F46EEQ36832810-0E6A47D4-A94F-4A14-9AF8-2FBC0C8E06F9Q37170088-BD9FD2AC-D493-4C2B-B061-952A155FD5AAQ37194005-2E793023-C034-4AC3-99D9-A4D817CE3BA3Q37746559-96711872-8BEA-4D81-9B5C-A3332F0E6BECQ37830843-64E701DD-7A62-4426-A211-B87287B757DAQ37932337-5BE2A4CD-5801-4141-8B64-54D92287F727Q38120801-EC33F36A-DE35-4DA4-80CA-BC9CD8992007Q38256919-170F05CA-7363-4429-B3B5-ECFA37F56487Q38312391-CFEE6368-57E7-47A8-A335-1A6EF8E546E3Q38314990-D4BCB9FE-BB5A-4ACA-975B-6E9116AAC6B0Q38912649-71615E41-46D2-4AB8-9D44-EA5F33D7962CQ38920095-6762B824-1D72-4704-B39E-A129EF55BBC2Q40197211-94634D66-3F04-406E-9C9C-9FBC69C80C6FQ40601689-0B73BC08-EFB3-49C6-966F-08C7A00E1502Q42047751-AD39379F-8366-4609-BABB-CA16AD79197AQ42626460-CDE9DBE4-8CFE-46AD-8F28-CA7909E607BBQ44123747-003741F2-91F2-4F40-BA6B-6BEE34C171A5Q44217415-2D62FE56-81AE-4A60-8ED9-BFC883F87B75Q44293002-E0F89D08-7E6D-4175-8E1E-87412303ACE4Q44820289-FCCD825B-8483-482E-A893-53578B487C46
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Noel Caplice
@ast
Noel Caplice
@en
Noel Caplice
@es
Noel Caplice
@nl
Noel Caplice
@sl
type
label
Noel Caplice
@ast
Noel Caplice
@en
Noel Caplice
@es
Noel Caplice
@nl
Noel Caplice
@sl
prefLabel
Noel Caplice
@ast
Noel Caplice
@en
Noel Caplice
@es
Noel Caplice
@nl
Noel Caplice
@sl
P106
P21
P31
P496
0000-0001-5445-1016